跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 541,549 条关于
“Chronic Pruritus of Unknown Origin”
全部
541,549
临床试验
492,800
药物
4,654
机构
3,318
资讯
40,777
去年
Galderma Launches Phase II Trials of Nemolizumab for Systemic Sclerosis and Chronic Pruritus of Unknown Origin
9个月前
Galderma Initiates Phase II Trial of Nemolizumab for Chronic Pruritus of Unknown Origin
去年
Attovia Therapeutics Initiates Phase 1 Trial of Novel Anti-IL-31 Therapy for Chronic Pruritus
2年前
FDA Expands Dupixent Label to Include Adolescent Patients with Chronic Rhinosinusitis with Nasal Polyps
去年
FDA Accepts Dupixent sBLA for Chronic Spontaneous Urticaria Treatment
去年
FDA Accepts Dupilumab sBLA for Chronic Spontaneous Urticaria Treatment
去年
FDA Accepts Dupixent sBLA for Chronic Spontaneous Urticaria Treatment
去年
Dupixent Shows Positive Phase 3 Results in Chronic Spontaneous Urticaria
去年
Dupixent Approved in EU for Eosinophilic Esophagitis in Young Children
去年
Dupixent Approved in China as First Biologic for COPD Patients
第 1 页，共 4078 页
上一页
下一页
